| scholarly article | Q13442814 |
| P50 | author | Leonardo Bocchi | Q57310552 |
| Daniele Del Rio | Q38801742 | ||
| Roberto Sala | Q44001594 | ||
| P2093 | author name string | Francesca Delucchi | |
| Luca Calani | |||
| Giulio Gabbiani | |||
| Donatella Stilli | |||
| Federico Quaini | |||
| Gallia Graiani | |||
| Christine Chaponnier | |||
| Costanza Lagrasta | |||
| Caterina Frati | |||
| Stefano Cavalli | |||
| Roberta Berni | |||
| P2860 | cites work | What is new for an old molecule? Systematic review and recommendations on the use of resveratrol | Q21089966 |
| Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology | Q26858965 | ||
| Release of chromatin protein HMGB1 by necrotic cells triggers inflammation | Q28131815 | ||
| Resveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1 | Q28567865 | ||
| High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes | Q28574795 | ||
| Oxidative Stress and Diabetic Complications | Q29615423 | ||
| Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
| Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy | Q33727613 | ||
| Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. | Q33994850 | ||
| Diabetic cardiomyopathy, causes and effects | Q34038623 | ||
| Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging | Q34212330 | ||
| Coronary microvascular dysfunction in diabetes mellitus: A review | Q34427072 | ||
| Stem cells and their niches | Q34507142 | ||
| Effect of low doses of red wine and pure resveratrol on circulating endothelial progenitor cells. | Q34584647 | ||
| Stem cell niches in the adult mouse heart | Q34657903 | ||
| Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats | Q34896614 | ||
| Beat-to-beat repolarization variability in ventricular myocytes and its suppression by electrical coupling. | Q51413150 | ||
| Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy. | Q52926321 | ||
| Assessment of left ventricular relaxation by Doppler echocardiography. Comparison of isovolumic relaxation time and transmitral flow velocities with time constant of isovolumic relaxation. | Q54100867 | ||
| α-Actin isoform distribution in normal and failing human heart: a morphological, morphometric, and biochemical study | Q59157167 | ||
| Diabetes Promotes Cardiac Stem Cell Aging and Heart Failure, Which Are Prevented by Deletion of the p66 shc Gene | Q59485549 | ||
| Alpha-skeletal actin is associated with increased contractility in the mouse heart | Q72314452 | ||
| Left ventricular volume and mass and their significance in heart disease | Q72381140 | ||
| Activation of gene expression in human neutrophils by high mobility group box 1 protein | Q73087842 | ||
| Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes | Q83756804 | ||
| Human cardiac stem cells | Q35956924 | ||
| Diabetic cardiomyopathy: the search for a unifying hypothesis | Q36423632 | ||
| Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase | Q36980730 | ||
| Re-expression of alpha skeletal actin as a marker for dedifferentiation in cardiac pathologies | Q37296164 | ||
| Oxidative stress regulation of stem and progenitor cells | Q37570482 | ||
| Oxidative stress: a key contributor to diabetic cardiomyopathy. | Q37731339 | ||
| The cardiovascular nutrapharmacology of resveratrol: pharmacokinetics, molecular mechanisms and therapeutic potential. | Q37758926 | ||
| Resveratrol and cardiovascular health | Q37788325 | ||
| Resveratrol in cardiovascular health and disease | Q37831927 | ||
| Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targets | Q37859918 | ||
| Administration of resveratrol: What formulation solutions to bioavailability limitations? | Q37943051 | ||
| MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel zinc-finger protein, MCPIP. | Q39772786 | ||
| Effects of resveratrol on H(2)O(2)-induced apoptosis and expression of SIRTs in H9c2 cells | Q39856822 | ||
| Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice | Q39963297 | ||
| Resveratrol inhibits foam cell formation via NADPH oxidase 1- mediated reactive oxygen species and monocyte chemotactic protein-1. | Q41837091 | ||
| Red wine antioxidant resveratrol-modified cardiac stem cells regenerate infarcted myocardium | Q42041083 | ||
| HMGB1: the missing link between diabetes mellitus and heart failure | Q42940012 | ||
| Oxidative and nitrative modifications of alpha-enolase in cardiac proteins from diabetic rats | Q43192593 | ||
| Akt downregulation by flavin oxidase-induced ROS generation mediates dose-dependent endothelial cell damage elicited by natural antioxidants | Q43218302 | ||
| The effects of resveratrol on cyclooxygenase-1 and cyclooxygenase-2 mRNA and protein levels in diabetic rat kidneys | Q43289250 | ||
| Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice | Q44708287 | ||
| Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC. | Q46030030 | ||
| Modulation of actin isoform expression before the transition from experimental compensated pressure-overload cardiac hypertrophy to decompensation | Q46104597 | ||
| Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol | Q46205363 | ||
| Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose | Q46369936 | ||
| Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats | Q46474680 | ||
| High glucose downregulates endothelial progenitor cell number via SIRT1. | Q46635826 | ||
| Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats | Q46977339 | ||
| Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling. | Q47282637 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| ImageQuant | Q112270642 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ventricular remodeling | Q7920323 |
| P304 | page(s) | e39836 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic rats | |
| P478 | volume | 7 |
| Q38114923 | Abnormalities of the cardiac stem and progenitor cell compartment in experimental and human diabetes |
| Q53668433 | Absorption, metabolism, and excretion of fermented orange juice (poly)phenols in rats. |
| Q55560479 | Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights. |
| Q55382866 | Astragalus polysaccharides protect cardiac stem and progenitor cells by the inhibition of oxidative stress-mediated apoptosis in diabetic hearts. |
| Q38245598 | Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update |
| Q48233660 | Diabetes mellitus and atrial remodelling in patients with paroxysmal atrial fibrillation: Role of electroanatomical mapping and catheter ablation |
| Q41340701 | Diabetes-Induced Oxidative Stress in Endothelial Progenitor Cells May Be Sustained by a Positive Feedback Loop Involving High Mobility Group Box-1 |
| Q37232675 | Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management |
| Q33690717 | Diabetic cardiomyopathy: where we are and where we are going |
| Q34775081 | Effects of resveratrol supplementation on bone growth in young rats and microarchitecture and remodeling in ageing rats |
| Q34622835 | HMGB1 in health and disease |
| Q28533775 | Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy |
| Q28066302 | High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications |
| Q46472199 | Impairments in mitochondrial palmitoyl-CoA respiratory kinetics that precede development of diabetic cardiomyopathy are prevented by resveratrol in ZDF rats |
| Q28085334 | Multipotent stem cells of the heart-do they have therapeutic promise? |
| Q37463353 | Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol. |
| Q27012551 | Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease |
| Q36776922 | Predictors and prevention of diabetic cardiomyopathy. |
| Q41643658 | Reduced HMGB 1-Mediated Pathway and Oxidative Stress in Resveratrol-Treated Diabetic Mice: A Possible Mechanism of Cardioprotection of Resveratrol in Diabetes Mellitus |
| Q53003626 | Remodeling of myocardium in rat with chronic dyslipidemia and under conditions of verapamil treatment. |
| Q91641055 | Resveratrol and Diabetic Cardiomyopathy: Focusing on the Protective Signaling Mechanisms |
| Q24618313 | Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence |
| Q58756915 | Resveratrol: A Double-Edged Sword in Health Benefits |
| Q38843402 | Stem cells and diabetic cardiomyopathy: from pathology to therapy |
| Q64249614 | The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes |
| Q30389310 | Using basic fibroblast growth factor nanoliposome combined with ultrasound-introduced technology to early intervene the diabetic cardiomyopathy |
Search more.